Show
Sort by
-
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
-
Six-minute walk test in systemic sclerosis patients without interstitial lung disease and pulmonary arterial hypertension
-
Six-minute walk test in systemic sclerosis patients
-
Stabilization of microcirculation in patients with early systemic sclerosis with diffuse skin involvement following rituximab treatment: an open-label study
-
Disease activity indices in systemic sclerosis : a systematic literature review
-
Six-minute walk test in systemic sclerosis : a systematic review and meta-analysis
-
Assessment of sensitivity to change of the European Scleroderma Study Group activity index
-
Six-minute walk test in systemic sclerosis : systematic review and meta-analysis
-
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement
-
Two years follow-up results after rituximab treatment (baseline and month 6) in patients with 'early' systemic sclerosis with diffuse skin involvement